Low number of KIR ligands in lymphoma patients favors a good rituximab-dependent NK cell response
Sign Up to like & getrecommendations! Published in 2021 at "Oncoimmunology"
DOI: 10.1080/2162402x.2021.1936392
Abstract: ABSTRACT The antibody-dependent cellular cytotoxicity (ADCC) effector function of natural killer (NK) cells is one of the known mechanisms of action for rituximab-based anti-cancer immunotherapy. Inhibition of the ADCC function of NK cells through interactions… read more here.
Keywords: rituximab dependent; kir ligands; cell; dependent cell ... See more keywords